Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 180,396,144
  • Shares Outstanding, K 1,765,474
  • Annual Sales, $ 33,266 M
  • Annual Income, $ 7,882 M
  • 60-Month Beta 0.72
  • Price/Sales 5.35
  • Price/Cash Flow 9.76
  • Price/Book 11.51
Trade ABBV with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 2.85
  • Number of Estimates 5
  • High Estimate 2.87
  • Low Estimate 2.84
  • Prior Year 2.21
  • Growth Rate Est. (year over year) +28.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.11 +29.16%
on 10/29/20
102.76 -0.56%
on 11/23/20
+17.84 (+21.15%)
since 10/23/20
3-Month
79.11 +29.16%
on 10/29/20
102.76 -0.56%
on 11/23/20
+7.32 (+7.72%)
since 08/21/20
52-Week
62.55 +63.36%
on 03/23/20
102.76 -0.56%
on 11/23/20
+16.13 (+18.74%)
since 11/22/19

Most Recent Stories

More News
Should You Buy the Dip in Horizon Therapeutics?

Horizon Therapeutics (HZNP) is a specialty and generic drug manufacturing company that relies on RGEN to build out its pipeline of drugs. The stock has taken off this year as two of its blockbuster drugs...

HZNP : 70.05 (-0.14%)
ABT : 109.27 (-1.46%)
ABBV : 102.18 (+1.33%)
PFE : 36.52 (-0.49%)
RGEN : 185.87 (-3.95%)
A Top Health-care Stock That's Paying 5.2% After Another Dividend Hike

If you can get a safe 5% yield in the markets right now, you shouldn't pass up the opportunity to do ...

ABBV : 102.18 (+1.33%)
AGN : 193.02 (+0.02%)
Major Depressive Disorder and Presbyopia Reviews Presented by AMCP Foundation/AbbVie, Inc. Specialized Health Outcomes Interns

, /PRNewswire/ -- AMCP Foundation recognizes two student pharmacists from the and for the successful completion of the Specialized Summer Internship Program in Health Outcomes, sponsored by AbbVie,...

ABBV : 102.18 (+1.33%)
Which Stocks Did Warren Buffett Buy and Sell In Q3?

Warren Buffett's Berkshire Hathaway (BRK.A)(BRK.B) trimmed shares of bank stocks, like JPMorgan Chase (JPM), PNC Financial Services (PNC), Wells Fargo (WFC), and M&T Bank (MTB), and bought shares of healthcare...

PFE : 36.52 (-0.49%)
TMUS : 127.88 (-1.39%)
SNOW : 274.15 (+3.06%)
BMY : 61.92 (+0.50%)
MRK : 80.28 (-0.21%)
ABBV : 102.18 (+1.33%)
3 “Strong Buy” Dividend Stocks Yielding More Than 4%

Amid a low interest rate environment and an uncertain market, investing in dividend stocks is one of the safer options. Companies like Verizon Communications, Inc. (VZ), AbbVie, Inc. (ABBV), KB Financial...

VZ : 60.23 (+0.32%)
ABBV : 102.18 (+1.33%)
KB : 41.79 (+0.94%)
AbbVie Announces Expiration and Final Results of Registered Exchange Offers

, /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) ("") announced today the expiration and final results of its offers to exchange (the "") any and all of its outstanding (i) aggregate principal amount of senior...

ABBV : 102.18 (+1.33%)
Constipation Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis

, /PRNewswire/ -- The report has been added to offering.

ABBV : 102.18 (+1.33%)
ALBO : 34.28 (-2.56%)
BAYRY : 14.2250 (+0.25%)
TKPYY : 16.5900 (-0.90%)
The Zacks Analyst Blog Highlights: AbbVie, Square, Honda Motor, Canadian Pacific Railway and Wayfair

The Zacks Analyst Blog Highlights: AbbVie, Square, Honda Motor, Canadian Pacific Railway and Wayfair

HMC : 29.11 (+1.15%)
CP : 328.92 (-0.93%)
ABBV : 102.18 (+1.33%)
W : 256.39 (+1.52%)
SQ : 207.78 (+6.03%)
Is AbbVie (ABBV) a Suitable Stock for Value Investors Now?

Let's see if AbbVie Inc. (ABBV) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

ABBV : 102.18 (+1.33%)
Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

, /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX Cosmetic Day on . The event is dedicated to celebrating the iconic treatment that helped...

AGN : 193.02 (+0.02%)
ABBV : 102.18 (+1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

2nd Resistance Point 103.70
1st Resistance Point 102.94
Last Price 102.18
1st Support Level 101.24
2nd Support Level 100.31

See More

52-Week High 102.76
Last Price 102.18
Fibonacci 61.8% 87.40
Fibonacci 50% 82.65
Fibonacci 38.2% 77.91
52-Week Low 62.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar